AUR300 - Aurinia Pharma
PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation. (PubMed, Mol Imaging Biol) - Aug 13, 2025 - "PET imaging reveals that obesity and T2D alter glucose metabolism and immune activation while suppressing tumor-immune activation in diabetic obese mice both within the tumor microenvironment and systemically." 
Journal • Brain Cancer • Breast Cancer • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Oncology • Solid Tumor • Type 2 Diabetes Mellitus • CD8 • GZMB • MRC1
http://www.ncbi.nlm.nih.gov/pubmed/40796714
 
Anna G Sorace; Benjamin M Larimer; Candace C Parker; Clayton C Yates; Heba M Alsheikh; Lalita A Shevde; Patrick N Song; Shannon E Lynch; Suzanne E Lapi; Yujun Zhang
 
Aug 13, 2025
 
Prev Next